Literature DB >> 9605260

Implications of gastric topical bioactive peptides in ammonia-induced acute gastric mucosal lesions in rats.

S Mori1, H Kaneko, T Mitsuma, T Hayakawa, C Yamaguchi, M Uruma.   

Abstract

BACKGROUND: Ammonia, one of the pathogenic factors in Helicobacter pylori-induced mucosal injury, induces acute mucosal lesions in the rat glandular stomach.
METHODS: The effect of ammonia administered intragastrically on gastric peptides was investigated in urethane-anesthetized rats.
RESULTS: Gastric mucosal lesions were observed 5 min after 0.3% ammonia (4 ml/kg, intragastrically). Immunoreactive endothelin-1 (ET-1) and immunoreactive thyrotropin-releasing hormone (TRH) concentrations in the gastric wall decreased significantly 2 min and 5 min after ammonia, respectively. A significant increase in gastric juice immunoreactive ET-1 and TRH levels was reciprocally observed. The severity of gastric mucosal injury and changes in gastric immunoreactive ET-1 and TRH concentrations were shown to be concentration-dependent 30 min after ammonia. Atropine (5 mg/kg, intraperitoneally, -20 min) prevented ammonia-induced injury accompanied by a block of changes in gastric immunoreactive ET-1 and TRH concentrations. BQ-485 (ET(A) receptor antagonist; 2 mg/kg, subcutaneously) also abolished ammonia-induced lesions and gastric immunoreactive TRH changes.
CONCLUSIONS: These findings suggested that gastric ET-1 and TRH play a role in ammonia-induced gastric mucosal injury mediated via a muscarine and an ET(A) receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605260     DOI: 10.1080/00365529850171017

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  1 in total

1.  Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication.

Authors:  Full-Young Chang; Chih-Yen Chen; Ching-Liang Lu; Jiing-Chyuan Luo; Rei-Hwa Lu; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.